NYMX Nymox Pharmaceutical Corporation

+0.05  (+3%)
Previous Close 1.73
Open 1.73
Price To Book 16.18
Market Cap 124,098,040
Shares 69,718,000
Volume 45,102
Short Ratio
Av. Daily Volume 59,310
Stock charts supplied by TradingView

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Data released February 2016 met endpoint
NX-1207 long-term NX03-0040 trial
Low grade localized prostate cancer
NDA filing due later in 2019.
NX-1207 Fexapotide